轴长动力学和儿童腹症中闭塞治疗的安全性:纵向分析
Wentong Yu1, Yunsi He1, Xuan Qiu1
1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China.
Investigative ophthalmology & visual science
|July 3, 2025
概括
对于视 (惰眼) 的闭塞治疗没有显著影响轴长度整体延长. 然而,特定的年龄组和基线特征显示出不同的反应,表明个性化治疗是最佳结果的关键.
科学领域:
- 眼科医生 眼科 眼科
- 儿科眼科医生 儿科眼科医生
- 视觉科学科学 视觉科学
背景情况:
- 眼,或惰的眼睛,是儿童视力减弱的常见原因.
- 闭塞疗法 (补丁) 是对眼的标准治疗方法.
- 了解闭塞对眼睛生长 (轴长) 的影响,对于长期视力健康至关重要.
研究的目的:
- 为了评估闭塞治疗对轴长度延长在患有眼的儿童的影响.
- 分析现实世界的大数据,以评估修补时间和眼睛生长之间的关系.
- 为了识别潜在的年龄和基线特定的阻塞疗法的潜在影响.
主要方法:
- 对2932名接受闭塞治疗的儿童 (3-15岁) 的回顾性分析.
- 来自中山眼科中心 (2019-2023) 的纵向数据.
- 多变量线性回归和通用估计方程 (GEE) 经过多个混因素的调整.
主要成果:
- 年平均轴长增加为0.23±0.22毫米.
- 总的来说,闭塞疗法对轴长度延长没有显著影响 (P=0.12).
- 校龄儿童 (6-12岁) 的修补眼睛有较短的基线轴长;学龄前儿童 (3-5岁) 的修补眼睛有较少的延长.
结论:
- 闭塞疗法是一种安全有效的眼治疗方法.
- 根据患者年龄和基线眼部特征量身定制闭塞方案,可以优化结果.
- 对年龄和基线特异性影响的进一步研究可以改进治疗策略.
相关概念视频
Angle Closure Glaucoma: Treatment
702
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
702
Open Angle Glaucoma: Treatment
583
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
583


